Cargando…
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Bladder cancer (BC) ranks as the sixth most prevalent cancer in the world, with a steady rise in its incidence and prevalence, and is accompanied by a high morbidity and mortality. BC is a complex disease with several molecular and pathological pathways, thus reflecting different behaviors depending...
Autores principales: | Batista, Rui, Vinagre, Nuno, Meireles, Sara, Vinagre, João, Prazeres, Hugo, Leão, Ricardo, Máximo, Valdemar, Soares, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169395/ https://www.ncbi.nlm.nih.gov/pubmed/31941070 http://dx.doi.org/10.3390/diagnostics10010039 |
Ejemplares similares
-
Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020) -
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
por: Batista, Rui, et al.
Publicado: (2020) -
Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
por: Soares, Paula, et al.
Publicado: (2011) -
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
por: Batista, Rui, et al.
Publicado: (2019) -
TERTmonitor—qPCR Detection of TERTp Mutations in Glioma
por: Brás, João Paulo, et al.
Publicado: (2023)